The regulation of MMPs and TIMPs in cartilage turnover

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 120-129

  Cawston, Tim ^a   Billington, Caron ^a   Cleaver, Catherine ^a   Elliott, Sarah ^a   Hui, Wang ^a   Koshy, Paul ^a   Shingleton, Bill ^a   Rowan, Andrew ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN; COLLAGENASE; INTERLEUKIN 1; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEOGLYCAN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; CARTILAGE CELL; CARTILAGE DEGENERATION; CATTLE; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DEGRADATION; TRANSCRIPTION REGULATION;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0032816413     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07678.x     Document Type: Conference Paper

References (21)

1. 1. Woessner, J.F., JR. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154.
2. 2. Cawston, T.E., W.A. Galloway, E. Mercer, G. Murphy & J.J. Reynolds. 1981. Purification of a rabbit bone inhibitor of collagenase. Biochem. J. 195: 159-165.
3. 3. Saklatvala, J., L.M.C. Pilsworth, S.J. Sarsfield, J. Gavrilovic & J.K. Heath. 1984. Pig catabolin is a form of interleukin-1. Biochem. J. 224: 461-466.
4. 4. Pettipher, E.R., G.A. Higgs & B. Henderson. 1986. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. USA 85: 8749-8753.
5. 5. Wood, D.D., E.J. Ihrie, C.A. Dinarello & P.L. Cohen. 1983. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum. 26: 975-983.
6. 6. Bunning, R.A.D., H.J. Richardson, A. Crawford, H. Skjodt, D. Hughes, D.B. Evans, M. Gowen, P.R.M. Dobson, B.L. Brown & R.G.G. Russell. 1986. The effcet of IL-1 on connective tissue metabolism and its relevance to arthritis. Agents Actions (Suppl.) 18: 131-152.
7. 7. Brinckerhoff, C.E. 1991. Joint destruction in arthritis: Metalloproteinases in the spotlight. Arthritis Rheum. 34: 1073-1075.
8. 8. Cawston, T.E. & A. Rowan. 1998. Prevention of cartilage breakdown by matrix metalloproteinase inhibition - a realistic therapeutic target. Brit. J. Rheumatol. 37: 353-356.
9. 9. Nixon, J.S., K.M.K. Bottomley, M.J. Broadhurst, P.A. Brown, W.H. Johnson, G. Lawton, J. Marley, A.D. Sedgwick & S.E. Wilkinson. 1991. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro. Int. J. Tiss. Reac. 13: 237-243.
10. 10. Andrews, H.J., T.A. Plumpton, G.P. Harper & T.E. Cawston. 1992. A synthetic peptide metalloprotecinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions 37: 147-154.
11. 11. Dingle, J.T., D.P. Pace Thomas, B. King & D.R. Bard. 1987. In vivo studies of articular tissue damage mediated by catabolin/interleukin-1. Ann. Rheum. Dis. 46: 527-533.
12. 12. Thomas, D.P.P., B. King, T. Stephens & J.T. Dingle. 1991. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1. Ann. Rheum. Dis. 50: 75-80.
13. 13. Fell, H.B, & R.W. Jubb. 1980. The breakdown of collagen by chondrocytes. J. Pathol. 130: 159-167.
14. 14. Farndale, R.W., D.J, Buttle & A.J. Barrett. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem. Biophys. Acta 883: 173-177.
15. 15. Bergman, I. & R. Loxley. 1963. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal. Biochem. 35: 1961-1965.
16. 16. Goldring, M.B., J.R. Birkdale, L-F. Suen, R. Yamin, S. Mizuno, J. Glowacki, J.L. Arbiser & J.F. Apperley. 1994. Interleukin 1β modified gene expression in immortalized human chondrocytes. J. Clin. Invest. 94: 2307-2316.
17. 17. Bigg, H.F. & Cawston, T.E. 1996. Effect of retinoic acid in combination with PDGF or TGFβ on TIMP-1 and MMP-1 secretion from human skin and synovial fibroblasts. J. Cell. Physiol. 166: 84-93.
18. 18. Billington, C.J., I.M. Clark & T.E, Cawston. 1998. An aggrecan degrading activity associated with chondrocyte membranes. Biochem. J. 336: 207-212.
19. 19. Ismaiel, S., R.M. Atkins, M.F. Pearce, P.A. Dieppe & C.J. Elson. 1992. Susceptibility of normal and arthritic cartilage to degradative stimuli. Brit. J. Rheumatol. 31: 369-373
20. 20. Cawston, T.E., V.A. Curry, C.A. Summers, I.M. Clark, G.P. Riley, P.F. Life, J.R. Spauli., M.B. Goldring, P.J.T. Koshy A.D. Rowan & W.D. Shingleton. 1998. The role of oncostatin M in animal and human connective tissue turnover and its localization within the rheumatoid joint. Arthritis Rheum. 41: 1760-1771.
21. 21. Sandy, J.D., C.R. Flannery, P.J. Neame & L.S. Lohmander. 1992. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J. Clin. Invest. 89: 1512-1516.